Diaphragmatic weakness after transcatheter arterial chemoembolization of the right inferior phrenic artery for treatment of hepatocellular carcinoma: a comparison of outcomes after N-butyl cyanoacrylate versus gelatin sponge embolization
- 23 December 2020
- journal article
- research article
- Published by SAGE Publications in Acta Radiologica
- Vol. 63 (1), 48-58
- https://doi.org/10.1177/0284185120981771
Abstract
The inferior phrenic artery (IPA) is the most common extrahepatic feeder for hepatocellular carcinoma (HCC) during transhepatic arterial chemoembolization (TACE). To compare the incidence of diaphragmatic weakness in patients with HCC after TACE of the right IPA conducted using either N-butyl cyanoacrylate (NBCA) or gelatin sponge particles. Medical records of 111 patients who underwent TACE of the right IPA using NBCA were retrospectively reviewed and compared with data from 135 patients with IPA embolization using gelatin sponge particles. The incidence of diaphragmatic weakness after the initial TACE procedure did not significantly differ between the groups (NBCA group 16.2%; gelatin sponge group 20.7%; P = 0.458). Five patients in the NBCA group and 11 in the gelatin sponge group showed spontaneous resolution of diaphragmatic weakness after a mean period of 3.5 months. Diaphragmatic weakness developed after the initial follow-up visit in 17 patients from the gelatin sponge group due to repeated TACE of the right IPA (mean 2.4 sessions; range 2–4 sessions), while it spontaneously developed without additional TACE procedures in one patient from the NBCA group. Permanent diaphragmatic weakness was less common in the NBCA than in the gelatin sponge group (12.6% and 25.2%, respectively; P = 0.017). The complete response rate did not significantly differ between the groups (NBCA group 16.2%; gelatin sponge group 25.9%; P = 0.065). Use of NBCA rather than gelatin sponge particles for TACE of the right IPA resulted in a lower incidence of permanent diaphragmatic weakness.Keywords
This publication has 33 references indexed in Scilit:
- Dysfunction of the diaphragmCurrent Opinion in Pulmonary Medicine, 2013
- Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSeminars in Liver Disease, 2010
- Cerebral lipiodol embolism following transcatheter arterial chemoembolization for hepatocellular carcinomaWorld Journal of Gastroenterology, 2010
- Development of Diaphragmatic Weakness after Transcatheter Arterial Chemoembolization of the Right Inferior Phrenic Artery: Frequency and Determinant FactorsJournal of Vascular and Interventional Radiology, 2009
- Transcatheter Arterial Embolization of Arterial Esophageal Bleeding with the Use of N-Butyl CyanoacrylateKorean Journal of Radiology, 2009
- Superselective Coil Embolization of Arterial Esophageal HemorrhageJournal of Vascular and Interventional Radiology, 2007
- Low Morbidity Associated With the Use of Nbca Liquid Adhesive for Preoperative Transarterial Embolization of Central Nervous System TumorsNeurosurgery, 2006
- Arterial Embolization of Unresectable Hepatocellular Carcinoma with Use of Microspheres, Lipiodol, and CyanoacrylateCardioVascular and Interventional Radiology, 2005
- Regional and Total Lung Function Studies in Patients with Hemidiaphragmatic ParalysisRespiration, 1975
- Diaphragm movements and the diagnosis of diaphragmatic paralysisClinical Radiology, 1966